Digital Therapeutics Program Lead Tools Guide: Evidence, Regulation, Engagement and a Step-by-Step Workflow

A Digital Therapeutics Program Lead guides the team that turns a clinically validated software intervention into a safe, regulated and widely used treatment. This guide covers the key tools, frameworks and standards, plus a clear workflow from clinical claim to post-market monitoring.

What a Digital Therapeutics Program Lead Does

This role combines programme management, clinical development and regulatory strategy. Typical responsibilities include:

• Defining the indication, intended use and clinical claims
• Coordinating clinical, regulatory, engineering, data science and commercial teams
• Planning clinical studies and evidence for regulators and payers
• Managing quality, risk, budget and timelines
• Overseeing vendors, such as research organisations and development partners
• Tracking engagement, outcomes and safety after launch

Tool Landscape at a Glance

What Makes a Digital Therapeutic Different

• Clinical claim: it aims to prevent, manage or treat a medical condition, not only to support wellness.
• Evidence: claims are usually supported by clinical studies, often randomised controlled trials.
• Regulation: many products are regulated as software as a medical device (SaMD), depending on intended use and region.
• Engagement matters: a treatment only works if patients keep using it as intended.
• Ongoing change: updates to content or algorithms need change control and sometimes regulatory review.

Regulatory and Quality References

Intervention Design Frameworks

• COM-B and the Behaviour Change Wheel: understanding capability, opportunity and motivation behind behaviour.
• Behaviour Change Technique Taxonomy: a standard list of techniques for describing intervention content.
• Person-Based Approach: shaping the intervention with patients’ views and needs.
• MRC framework for complex interventions: guidance on developing, testing and evaluating interventions.

Include patients and clinicians in co-design so the programme fits real life and care pathways.

Evidence and Study Design Tools

Choose clinically meaningful endpoints, a suitable control (such as sham or standard care) and a pre-specified analysis plan.

Data Capture and Trial Platforms

Outcome Measures

• PROMIS: patient-reported measures across many health areas.
• PHQ-9 and GAD-7: short questionnaires for depression and anxiety symptoms.
• EQ-5D: a generic measure of health-related quality of life.
• System Usability Scale: quick measure of perceived usability.
• Engagement and adherence measures: sessions completed, retention and use as prescribed.

Check licence terms and validation status of each questionnaire for your population and language.

Engineering Tools

Keep requirements traceability and design controls in line with your quality system.

Engagement and Analytics Tools

• Amplitude and Mixpanel: product analytics for journeys, retention and feature use.
• Braze: customer messaging across push, email and in-app channels.
• OneSignal: push notification delivery.
• Metabase: dashboards and SQL reporting.

Confirm whether each tool can handle health data and whether a business associate agreement or equivalent contract is available. Avoid sensitive details in notifications.

Wearables and Remote Data

• Validic: aggregating data from many wearable and health devices.
• Garmin Health API: access to data from Garmin devices.
• Oura API: access to sleep and readiness data from Oura users.
• Bluetooth Low Energy: the standard wireless link used by many sensors.

Validate that consumer device data is accurate enough for your intended use before relying on it for clinical decisions.

Privacy and Security References

Programme Management Tools

• Jira and Asana: task tracking across engineering and operations.
• Smartsheet: timelines, budgets and resource planning.
• Confluence: shared documentation and decisions.
• Greenlight Guru: design controls and quality records for medical devices.

Use stage gates with clear criteria, such as clinical readiness, regulatory readiness and commercial readiness, and keep a risk and issue log.

Step-by-Step Workflow

1. Define indication and claim. Specify the condition, patients, intended use, endpoints and what the product claims to do.
2. Design the intervention. Use a behaviour change model, co-design with patients and clinicians, and write clear content and rules.
3. Set regulatory path and quality system. Determine SaMD classification, choose the market route and put design controls and risk management in place.
4. Build the product. Develop a secure app with data capture, integrations and engagement features, with traceability and testing.
5. Generate evidence. Run pilot and pivotal studies, register and pre-specify them, and report using CONSORT-EHEALTH.
6. Submit and launch. Complete regulatory submissions, prepare payer and health-system evidence, and onboard clinicians and patients.
7. Monitor and improve. Track engagement, outcomes and safety, run post-market surveillance and manage every update through change control.

Checklist and Common Mistakes

• Claim: is the intended use clear and supported by evidence?
• Evidence: are endpoints meaningful and pre-specified?
• Engagement: will patients realistically use it as intended?
• Change control: are updates assessed for safety and regulatory impact?

Frequently Asked Questions

Conclusion

A strong digital therapeutics programme links a clear clinical claim, a well-designed intervention, rigorous evidence, quality systems and privacy protection. Plan regulation early, measure engagement and outcomes and manage every change carefully. Always confirm current regulations, standards and product details in official sources.